Literature DB >> 34567927

Glycemic control status, diabetes management patterns, and clinical characteristics of adults with type 1 diabetes in Japan: Study of Adults' Glycemia in T1DM subanalysis.

Norio Abiru1, Akira Shimada2, Rimei Nishimura3, Munehide Matsuhisa4, Asuka Ozaki5, Hiroshi Ikegami6.   

Abstract

AIMS/
INTRODUCTION: Type 1 diabetes is rare in the general Japanese population, but becoming more common in adults with increased longevity owing to advancements in treatment. We aimed to examine the current state of glycemic control and diabetes management using real-world data on Japanese adults with type 1 diabetes in different age groups.
MATERIALS AND METHODS: This was a subanalysis of Japanese participants from a multinational, cross-sectional, observational study of adults with type 1 diabetes aged ≥ 26 years conducted in 2018 (Study of Adults' Glycemia in T1DM). Glycemic control achievement rate and goal setting, incidence of hypoglycemia, and diabetes management of individuals aged 26‒44 years, 45‒64 years, and ≥ 65 years were summarized.
RESULTS: The data on 528 participants were analyzed. The mean glycated hemoglobin (HbA1c) value was 7.8% (61.3 mmol/mol). Of the participants, 25.8% achieved an HbA1c level of < 7.0% (26-44 years, 33.7%; 45‒64 years, 18.9%; and ≥ 65 years, 24.3%). In total, 71.4% participants reported ≥ 1 symptomatic hypoglycemic episode within the last 3 months, and 5.5% participants reported ≥ 1 severe hypoglycemic episode within the last 6 months. A less stringent individualized goal was set for participants aged ≥ 65 years; they had the lowest incidence of ≥ 1 symptomatic hypoglycemic episode. Insulin pumps and continuous glucose monitoring were used in 23.5% and 33.9% participants, respectively.
CONCLUSION: Glycemic control was suboptimal; the low incidence of severe hypoglycemia suggests careful glycemic control, balancing benefits and risks, particularly in Japanese adults aged ≥ 65 years with type 1 diabetes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s13340-021-00504-7. © The Japan Diabetes Society 2021, corrected publication 2021.

Entities:  

Keywords:  Adults; Glycemic control; HbA1c; Hypoglycemia; Japan; Type 1 diabetes mellitus

Year:  2021        PMID: 34567927      PMCID: PMC8413413          DOI: 10.1007/s13340-021-00504-7

Source DB:  PubMed          Journal:  Diabetol Int        ISSN: 2190-1678


  23 in total

1.  Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.

Authors:  Kellee M Miller; Nicole C Foster; Roy W Beck; Richard M Bergenstal; Stephanie N DuBose; Linda A DiMeglio; David M Maahs; William V Tamborlane
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

2.  The Percentage of Continuous Subcutaneous Insulin Infusion Usage Among Adult Type 1 Diabetes Mellitus Patients in Japan: A Cross-Sectional Study at National Hospital Organization Hospitals.

Authors:  Takashi Murata; Yuji Aoki; Yasuhisa Kato; Tsuyoshi Tanaka; Rika Araki; Ken Kato; Kazuyuki Hida; Tomokazu Kawamura; Kazuya Yoshida; Youichi Imamura; Tetsushi Toyonaga; Kazunori Yamada; Naoki Sakane
Journal:  J Diabetes Sci Technol       Date:  2017-09

3.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

4.  Carbohydrate-to-insulin ratio is estimated from 300-400 divided by total daily insulin dose in type 1 diabetes patients who use the insulin pump.

Authors:  Akio Kuroda; Tetsuyuki Yasuda; Mitsuyoshi Takahara; Fumie Sakamoto; Ryuichi Kasami; Kazuyuki Miyashita; Sumiko Yoshida; Eri Kondo; Ken-ichi Aihara; Itsuro Endo; Taka-aki Matsuoka; Hideaki Kaneto; Toshio Matsumoto; Iichiro Shimomura; Munehide Matsuhisa
Journal:  Diabetes Technol Ther       Date:  2012-11       Impact factor: 6.118

5.  Time trends in mortality rates in type 1 diabetes from 2002 to 2011.

Authors:  Marit E Jørgensen; Thomas P Almdal; Bendix Carstensen
Journal:  Diabetologia       Date:  2013-08-16       Impact factor: 10.122

Review 6.  7. Diabetes Technology: Standards of Medical Care in Diabetes-2020.

Authors: 
Journal:  Diabetes Care       Date:  2020-01       Impact factor: 19.112

Review 7.  2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020.

Authors: 
Journal:  Diabetes Care       Date:  2020-01       Impact factor: 19.112

8.  Basal insulin requirement is ~30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump.

Authors:  Akio Kuroda; Hideaki Kaneto; Tetsuyuki Yasuda; Munehide Matsuhisa; Kazuyuki Miyashita; Noritaka Fujiki; Keiko Fujisawa; Tsunehiko Yamamoto; Mitsuyoshi Takahara; Fumie Sakamoto; Taka-Aki Matsuoka; Iichiro Shimomura
Journal:  Diabetes Care       Date:  2011-03-23       Impact factor: 19.112

9.  Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort.

Authors:  Rachel G Miller; Aaron M Secrest; Ravi K Sharma; Thomas J Songer; Trevor J Orchard
Journal:  Diabetes       Date:  2012-07-30       Impact factor: 9.461

10.  The SAGE study: Global observational analysis of glycaemic control, hypoglycaemia and diabetes management in T1DM.

Authors:  Eric Renard; Hiroshi Ikegami; André Gustavo Daher Vianna; Paolo Pozzilli; Sandrine Brette; Zsolt Bosnyak; Felipe Lauand; Anne Peters; Valerie Pilorget; Dubravka Jurišić-Eržen; Jothydev Kesavadev; Jochen Seufert; Emma G Wilmot
Journal:  Diabetes Metab Res Rev       Date:  2021-03-02       Impact factor: 4.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.